loading

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
17.43%
16.59
14.12 14.31 12.33 10.66
Operating Income/Loss
17.43%
-16.59
-14.12 -14.31 -12.33 -10.66
Nonoperating Income/Loss
26.43%
1.626
2.21 1.543 1.111 1.148
Income/Loss From Continuing Operations Before Tax
25.57%
-14.96
-11.91 -32.54 -11.22 -9.513
Income/Loss From Continuing Operations After Tax
25.57%
-14.96
-11.91 -12.77 -11.22 -9.513
Net Income/Loss
25.57%
-14.96
-11.91 -12.77 -11.22 -9.513
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.84%
42.27
40.71 2.2503 22.33 21.23
Diluted Average Shares
3.84%
42.27
40.71 2.2503 22.33 21.23
Basic Earnings Per Share
20.69%
-0.35
-0.29 -0.43 -0.50 -0.45
Diluted Earnings Per Share
20.69%
-0.35
-0.29 -0.43 -0.50 -0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.58
price down icon 1.59%
$86.42
price up icon 0.06%
$27.34
price down icon 0.85%
$108.26
price down icon 2.97%
$146.15
price up icon 0.66%
biotechnology ONC
$342.21
price up icon 0.16%
Kapitalisierung:     |  Volumen (24h):